|
Real-time Estimate
Cboe Europe
03:30:15 26/08/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 166.60 SEK | +1.59% |
|
+5.10% | +4.83% |
| 18/08 | Citadel Advisors no longer a disclosed short-seller in Cellavision | FW |
| 20/07 | Danske Bank raises Cellavision target price to 187 kronor (180), reiterates buy - BN | FW |
Company Valuation: CellaVision AB
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 7,757 | 5,462 | 5,057 | 5,188 | 3,749 | 3,912 | - | - |
| Change | - | -29.58% | -7.42% | 2.59% | -27.72% | 4.33% | - | - |
| Enterprise Value (EV) 1 | 7,763 | 5,456 | 5,000 | 5,065 | 3,587 | 3,724 | 3,690 | 3,633 |
| Change | - | -29.71% | -8.37% | 1.31% | -29.18% | 3.83% | -0.92% | -1.53% |
| P/E | 61.9x | 46.2x | 38.8x | 36.9x | 24.5x | 28.1x | 22.4x | 19.8x |
| PBR | 14.3x | 8.51x | 7.06x | 6.36x | 4.22x | 4.04x | 3.67x | 3.3x |
| PEG | - | -8.36x | 3.8x | 4.58x | 2.78x | -3.07x | 0.9x | 1.5x |
| Capitalization / Revenue | 13.7x | 8.54x | 7.47x | 7.17x | 4.94x | 5.05x | 4.5x | 4.14x |
| EV / Revenue | 13.7x | 8.53x | 7.38x | 7x | 4.73x | 4.8x | 4.24x | 3.85x |
| EV / EBITDA | 39.6x | 27.5x | 24.2x | 23.2x | 14.9x | 16.4x | 13.3x | 11.7x |
| EV / EBIT | 47.7x | 34.5x | 29.9x | 28.5x | 17.8x | 21x | 16.6x | 14.3x |
| EV / FCF | 68x | 81.1x | 45.1x | 41.4x | 31.4x | 34.5x | 32.9x | 26x |
| FCF Yield | 1.47% | 1.23% | 2.22% | 2.42% | 3.19% | 2.9% | 3.04% | 3.84% |
| Dividend per Share 2 | 2 | 2 | 2.25 | 2.5 | 2.75 | 2.75 | 3.133 | 3.4 |
| Rate of return | 0.62% | 0.87% | 1.06% | 1.15% | 1.75% | 1.68% | 1.91% | 2.07% |
| EPS 2 | 5.25 | 4.96 | 5.46 | 5.9 | 6.42 | 5.831 | 7.313 | 8.294 |
| Distribution rate | 38.1% | 40.3% | 41.2% | 42.4% | 42.8% | 47.2% | 42.8% | 41% |
| Net sales 1 | 565.6 | 639.3 | 677.3 | 723.2 | 759 | 775.1 | 870 | 944.7 |
| EBITDA 1 | 196.2 | 198.4 | 206.8 | 218.7 | 241.4 | 227.3 | 277.7 | 309.5 |
| EBIT 1 | 162.7 | 158.3 | 167.1 | 177.7 | 202.1 | 177.5 | 222.9 | 253.3 |
| Net income 1 | 125.3 | 118.3 | 130.3 | 140.7 | 153.1 | 139 | 174.4 | 197.7 |
| Net Debt 1 | 6.368 | -5.558 | -56.94 | -122.6 | -162.6 | -187.5 | -221.9 | -278.4 |
| Reference price 2 | 325.20 | 229.00 | 212.00 | 217.50 | 157.20 | 164.00 | 164.00 | 164.00 |
| Nbr of stocks (in thousands) | 23,852 | 23,852 | 23,852 | 23,852 | 23,852 | 23,852 | - | - |
| Announcement Date | 04/02/22 | 08/02/23 | 07/02/24 | 06/02/25 | 05/02/26 | - | - | - |
1SEK in Million2SEK
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 28.12x | 4.8x | 16.38x | 1.68% | 41Cr | |
| 64.68x | 5.06x | 16.9x | 0.33% | 1.78TCr | |
| 39.95x | - | - | 2.03% | 172.58Cr | |
| -3.66x | 1.47x | 6.81x | - | 103.21Cr | |
| 15.85x | 2.22x | 7.46x | 1.48% | 96Cr | |
| 49.01x | - | - | - | 78Cr | |
| 147.79x | - | - | 0.61% | 56Cr | |
| 21.9x | 3.12x | 13.34x | 1.56% | 46Cr | |
| -11.79x | - | - | - | 45Cr | |
| Average | 39.09x | 3.34x | 12.18x | 1.28% | 268.8Cr | |
| Weighted average by Cap. | 56.61x | 4.70x | 15.87x | 0.57% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- CEVI Stock
- Valuation CellaVision AB
Select your edition
All financial news and data tailored to specific country editions
